TP
Tapan Paul
Active Director Director DIN 10094483
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2023
Shareholding value •••• Premium profile
About Tapan Paul
Data last updated:
Tapan Paul is a Director at Duckbill Drugs Pvt Ltd (since 2023). The company operates in Pharma. Duckbill Drugs Pvt Ltd reported revenue of ₹7.20 Cr (FY 2025).
DIN 10094483
Primary Designation Director
Industry Pharma
First Appointment 30 Mar 2023
Oldest Company Age 32 yrs
Largest company Duckbill Drugs Pvt Ltd · ₹7.20 Cr (FY 2025)
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 30 Mar 2023 | 1994 | ₹7.20 Cr (FY 2025) | Active |
Board colleagues of Tapan Paul
| Name | DIN | Company | Designation |
|---|---|---|---|
| Asoke Kumar Paul | 10093465 | Duckbill Drugs Pvt Ltd | Director |
| Reeta Paul | 10094479 | Duckbill Drugs Pvt Ltd | Director |
| Sangita Paul | 10094482 | Duckbill Drugs Pvt Ltd | Director |
Directorship timeline
Open interactive timeline →Duckbill Drugs Pvt Ltd
Premium access
Shareholding and investment profile for Tapan Paul
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Tapan Paul
Tapan Paul currently holds 1 directorship: Duckbill Drugs Pvt Ltd (Director, since 30 Mar 2023, revenue ₹7.20 Cr (FY 2025)).
Tapan Paul was first appointed on 30 Mar 2023 as Director at Duckbill Drugs Pvt Ltd.
The current boards of Tapan Paul's companies include Asoke Kumar Paul (Duckbill Drugs Pvt Ltd), Reeta Paul (Duckbill Drugs Pvt Ltd), Sangita Paul (Duckbill Drugs Pvt Ltd).